Fangping Zhao

3.9k total citations · 2 hit papers
21 papers, 3.0k citations indexed

About

Fangping Zhao is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Fangping Zhao has authored 21 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Cancer Research and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Fangping Zhao's work include Cancer, Hypoxia, and Metabolism (3 papers), Genetic factors in colorectal cancer (3 papers) and Cancer-related Molecular Pathways (3 papers). Fangping Zhao is often cited by papers focused on Cancer, Hypoxia, and Metabolism (3 papers), Genetic factors in colorectal cancer (3 papers) and Cancer-related Molecular Pathways (3 papers). Fangping Zhao collaborates with scholars based in United States, China and Ethiopia. Fangping Zhao's co-authors include Craig B. Thompson, Charalambos Andreadis, Daniel E. Bauer, Georgia Hatzivassiliou, Xuemei Tong, Benoı̂t Viollet, Ralph J. DeBerardinis, Ravi K. Amaravadi, Monica Buzzai and Julian J. Lum and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Cancer Cell.

In The Last Decade

Fangping Zhao

20 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ATP citrate lyase inhibition can suppress tumor cell growth

2005 820 citations Georgia Hatzivassiliou, Fangping Zhao et al. Cancer Cell profile →
Systemic Treatment with the Antidiabetic Drug Metformin Selectively Impairs p53-Deficient Tumor Cell Growth

2007 756 citations Monica Buzzai, Russell G. Jones et al. Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fangping Zhao United States	12	2.2k	1.5k	592	516	343	21	3.0k
Monica Buzzai United States	13	3.1k 1.4×	1.8k 1.2×	508 0.9×	966 1.9×	467 1.4×	13	4.0k
Zhao Lin China	26	2.1k 1.0×	1.8k 1.2×	325 0.5×	636 1.2×	132 0.4×	43	3.0k
Wenjing Du China	20	1.8k 0.8×	1.3k 0.9×	207 0.3×	623 1.2×	186 0.5×	36	2.7k
William W. Wheaton United States	9	3.2k 1.5×	2.2k 1.5×	289 0.5×	790 1.5×	325 0.9×	9	4.3k
Jean-Marc Herbert France	7	1.8k 0.8×	1.5k 1.0×	279 0.5×	392 0.8×	298 0.9×	7	3.0k
Brian F. Clem United States	25	2.0k 0.9×	1.6k 1.1×	166 0.3×	594 1.2×	176 0.5×	52	2.8k
Christopher J. Halbrook United States	17	1.5k 0.7×	958 0.6×	377 0.6×	1.2k 2.4×	365 1.1×	25	2.7k
Yekaterina Y. Zaytseva United States	24	1.4k 0.6×	1.0k 0.7×	213 0.4×	368 0.7×	157 0.5×	49	2.1k
Dimitrios Anastasiou United Kingdom	15	1.7k 0.8×	981 0.7×	179 0.3×	384 0.7×	107 0.3×	30	2.5k
Alba Luengo United States	11	1.8k 0.8×	1.4k 1.0×	146 0.2×	396 0.8×	152 0.4×	15	2.5k

Countries citing papers authored by Fangping Zhao

Since Specialization

Citations

This map shows the geographic impact of Fangping Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangping Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangping Zhao more than expected).

Fields of papers citing papers by Fangping Zhao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fangping Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangping Zhao. The network helps show where Fangping Zhao may publish in the future.

Co-authorship network of co-authors of Fangping Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Fangping Zhao. A scholar is included among the top collaborators of Fangping Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fangping Zhao. Fangping Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shi, Jingyun, et al.. (2024). The Status and Influencing Factors of COVID-19 Vaccination for 3–7-Year-Old Children Born Prematurely. Patient Preference and Adherence. Volume 18. 787–796.

Tian, Panwen, Xiaoyan Zhang, Sheng Yang, et al.. (2022). Characteristics of TP53 germline variants and their correlations with Li-Fraumeni syndrome or Li-Fraumeni-like syndrome in Chinese tumor patients. Journal of genetics and genomics. 49(7). 645–653. 3 indexed citations

Wu, Xi, Puyuan Xing, Min Shi, et al.. (2022). Cerebrospinal Fluid Cell-Free DNA-Based Detection of High Level of Genomic Instability Is Associated With Poor Prognosis in NSCLC Patients With Leptomeningeal Metastases. Frontiers in Oncology. 12. 664420–664420. 14 indexed citations

Zhang, Chuan, Yupei Wang, Jingyun Shi, et al.. (2022). Identification of a novel ANK1 mutation in hereditary spherocytosis co‐existing with BWS. Molecular Genetics & Genomic Medicine. 10(4). e1903–e1903. 2 indexed citations

Li, Ziyu, Yongning Jia, Honglin Zhu, et al.. (2021). Tumor mutation burden is correlated with response and prognosis in microsatellite-stable (MSS) gastric cancer patients undergoing neoadjuvant chemotherapy. Gastric Cancer. 24(6). 1342–1354. 21 indexed citations

Wang, Hongyan, Xiaoling Liu, Youliang Wang, et al.. (2021). The effect of continuous clustered care on the physical growth of preterm infants and the satisfaction with the nursing care.. American Journal of Translational Research. 13(6). 7376–7381. 3 indexed citations

Lei, Kefeng, Ran Sun, Lee H. Chen, et al.. (2018). Mutant allele quantification reveals a genetic basis for TP53 mutation-driven castration resistance in prostate cancer cells. Scientific Reports. 8(1). 12507–12507. 5 indexed citations

Baig, Shahid Mahmood, Ambrin Fatima, Muhammad Tariq, et al.. (2018). Hereditary brain tumor with a homozygous germline mutation in PMS2: pedigree analysis and prenatal screening in a family with constitutional mismatch repair deficiency (CMMRD) syndrome. Familial Cancer. 18(2). 261–265. 2 indexed citations

Jia, Shuqin, Yu Sun, Hai Yan, et al.. (2018). A Chinese family affected by lynch syndrome caused by MLH1 mutation. BMC Medical Genetics. 19(1). 106–106. 2 indexed citations

10.

Yan, Yousheng, et al.. (2015). [Congenital central hypoventilation syndrome: analysis of PHOX2B gene mutation in a case].. PubMed. 32(5). 665–9. 1 indexed citations

11.

Zhang, Zhenyu, Aden Ka‐Yin Chan, Xiaojie Ding, et al.. (2015). TERTpromoter mutations contribute toIDHmutations in predicting differential responses to adjuvant therapies in WHO grade II and III diffuse gliomas. Oncotarget. 6(28). 24871–24883. 29 indexed citations

12.

Tong, Xuemei, Fangping Zhao, & Craig B. Thompson. (2009). The molecular determinants of de novo nucleotide biosynthesis in cancer cells. Current Opinion in Genetics & Development. 19(1). 32–37. 263 indexed citations

13.

Tong, Xuemei, Fangping Zhao, Anthony Mancuso, Joshua J. Gruber, & Craig B. Thompson. (2009). The glucose-responsive transcription factor ChREBP contributes to glucose-dependent anabolic synthesis and cell proliferation. Proceedings of the National Academy of Sciences. 106(51). 21660–21665. 115 indexed citations

14.

Guerriero, Jennifer L., Dara Ditsworth, Yongjun Fan, et al.. (2008). Chemotherapy Induces Tumor Clearance Independent of Apoptosis. Cancer Research. 68(23). 9595–9600. 43 indexed citations

15.

Kundu, Mondira, Tullia Lindsten, Junmin Wu, et al.. (2008). Ulk1 plays a critical role in the autophagic clearance of mitochondria and ribosomes during reticulocyte maturation. Blood. 112(4). 1493–1502. 454 indexed citations

16.

Buzzai, Monica, Russell G. Jones, Ravi K. Amaravadi, et al.. (2007). Systemic Treatment with the Antidiabetic Drug Metformin Selectively Impairs p53-Deficient Tumor Cell Growth. Cancer Research. 67(14). 6745–6752. 756 indexed citations breakdown →

17.

Bauer, Daniel E., Georgia Hatzivassiliou, Fangping Zhao, Charalambos Andreadis, & Craig B. Thompson. (2005). ATP citrate lyase is an important component of cell growth and transformation. Oncogene. 24(41). 6314–6322. 418 indexed citations

18.

Hatzivassiliou, Georgia, Fangping Zhao, Daniel E. Bauer, et al.. (2005). ATP citrate lyase inhibition can suppress tumor cell growth. Cancer Cell. 8(4). 311–321. 820 indexed citations breakdown →

19.

Zhao, Fangping, et al.. (2001). The involvement of Ran GTPase in lipopolysaccharide endotoxin-induced responses. Journal of Endotoxin Research. 7(1). 53–56. 8 indexed citations

20.

Yuan, Quan, et al.. (2000). Dominant negative down-regulation of endotoxin-induced tumor necrosis factor α production byLps^d/Ran. Proceedings of the National Academy of Sciences. 97(6). 2852–2857. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact